Italy Microrna Market Size & Outlook, 2026-2033
Related Markets
Italy microrna market highlights
- The Italy microrna market generated a revenue of USD 52.7 million in 2025 and is expected to reach USD 135.8 million by 2033.
- The Italy market is expected to grow at a CAGR of 12.7% from 2026 to 2033.
- In terms of segment, services was the largest revenue generating scope in 2025.
- Services is the most lucrative scope segment registering the fastest growth during the forecast period.
Microrna market data book summary
| Market revenue in 2025 | USD 52.7 million |
| Market revenue in 2033 | USD 135.8 million |
| Growth rate | 12.7% (CAGR from 2026 to 2033) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Horizon Discovery, NanoString Technologies, Merck KGaA, Takara Bio Inc, LGC Group, Biogenex, New England Biolabs, GeneCopoeia |
Other key industry trends
- In terms of revenue, Italy accounted for 2.7% of the global microrna market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, UK microrna market is projected to lead the regional market in terms of revenue in 2033.
- UK is the fastest growing regional market in Europe and is projected to reach USD 338.9 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
MicroRNA Market Scope
MicroRNA Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GeneCopoeia | View profile | 1-10 | Rockville, Maryland, United States, North America | https://www.genecopoeia.com/ |
| NanoString Technologies | View profile | 251-500 | Seattle, Washington, United States, North America | http://www.nanostring.com |
| Biogenex | View profile | 51-100 | Fremont, California, United States, North America | https://biogenex.com |
| Horizon Discovery | View profile | 101-250 | Cambridge, Cambridgeshire, United Kingdom, Europe | http://www.horizondiscovery.com |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | http://neb.com |
| LGC Group | View profile | 1001-5000 | Teddington, Gloucestershire, United Kingdom, Europe | http://www.lgcgroup.com/ |
| Takara Bio Inc | View profile | 1793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | http://www.takara-bio.co.jp |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Italy microrna market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microrna market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 66.03% in 2025. Horizon Databook has segmented the Italy microrna market based on product, services covering the revenue growth of each sub-segment from 2021 to 2033.
Italy has a strong collaboration between scientists and clinicians, thus possessing a robust clinical capacity in the early stages of clinical testing. Three of ten gene therapy products approved in Europe have been developed in Italy.
Italy contributed to half of six commercially available gene and cell therapy products. Positive outcomes of Strimvelis have resulted in increasing investments in cell and gene therapy research in the country. This indicates its significant contributions to advanced therapy products.
The increasing engagement of homegrown companies in stem cell research is expected to drive the market in the country. For instance, in September 2019, Genenta Science, an Italian biotechnology company, raised USD 15.68 million (EUR 13.2 million) to fund two ongoing phase I/II clinical trials of stem cell therapy.
Reasons to subscribe to Italy microrna market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy microrna market databook
-
Our clientele includes a mix of microrna market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy microrna market , including forecasts for subscribers. This country databook contains high-level insights into Italy microrna market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Italy Product - Microrna Market, 2025 - 2033 (US$M)
Italy MicroRNA Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
